Nairobi, Kenya — The International Vaccine Institute (IVI), in partnership with the KAVI–Institute of Clinical Research (KAVI-ICR) at the University of Nairobi, has officially launched a Phase 2 clinical trial of a novel cholera conjugate vaccine. This study is now actively recruiting adults and children from Nairobi City County to take part in what could be a significant advance in cholera prevention.

The University of Nairobi's annual STD/HIV/SRH Collaborative Research Group meeting kicked off on Monday, January 26, 2026, at the Serena Hotel, bringing together leading scientists, public health experts, and stakeholders. The opening days set a powerful tone, emphasizing not just scientific presentation but crucial dialogue on the future of research in a changing global landscape.

Day 1: Setting the Stage for Strategic Dialogue